Luteal Phase Support In IVF Women Using GnRH Agonist
Launched by NATIONAL UNIVERSITY OF MALAYSIA · Nov 20, 2019
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
This was a retrospective study on selected patients who underwent IVF treatment under MAC (Medically Assisted Conception) Unit, University Kebangsaan Malaysia Medical Centre for the period of June 2015-June 2018. Their medical records were reviewed, and data analysed.
The sample size was calculated using Power \& Sample Size Calculator by Dupont \& Plummer 1998 for dichotomous response version 3.1.2 \[6\]. Based on this formula, a is the type I error probability for a two-sided test allowable about 5% in this study. The power of certainty is the percentage of estimated power of this study....
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • underwent ICSI
- • given progestogens plus GnRH agonist or progestogens only as luteal phase support.
- Exclusion Criteria:
- • different luteal phase support
- • frozen embryo transfer and
- • missing medical records data
About National University Of Malaysia
The National University of Malaysia (Universiti Kebangsaan Malaysia, UKM) is a prestigious institution dedicated to advancing medical research and clinical trials that contribute significantly to the fields of healthcare and biomedical sciences. As a leading academic and research university, UKM is committed to fostering innovation and excellence in clinical research, promoting collaboration among multidisciplinary teams, and enhancing the quality of patient care. The university's robust infrastructure and experienced research faculty facilitate rigorous clinical trials aimed at addressing critical health challenges, thereby improving health outcomes both locally and globally. Through its dedication to ethical research practices and adherence to regulatory standards, UKM strives to enhance the understanding of diseases and develop effective interventions that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cheras, Kuala Lumpur, Malaysia
Patients applied
Trial Officials
Muhammad Azrai Abu, Medical Degree
Principal Investigator
Department of Obstetrics and Gynecology, UKM Medical Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials